CASP9 and lung carcinoma: Further, in ebractenoid F-treated A549 and H460 human lung cancer cells, the expression levels of cancer growth- and migration-associated proteins decreased, as well as those of cell death-associated proteins (Bax, cleaved caspase-3 and cleaved caspase-9).